HFCAS OpenIR

浏览/检索结果: 共3条,第1-3条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Clinical effectiveness of apatinib at different doses in patients with advanced gastric cancer as the third-line or further treatment: Results from a post-marketing phase IV study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Li, Jin;  Qin, Shukui;  Wen, Lu;  Wang, Junsheng;  Deng, Wenying;  Guo, Weijian;  Jia, Tongfu;  Zhao, Qun;  Zhang, Guifang;  He, Yifu;  Zhong, Haijun;  Ba, Yi;  Lin, Xiaoyan;  Yang, Jianwei;  Zhao, Jun;  Bai, Yuxian;  Sun, Guogui;  Wu, Yongjuan;  Wang, Meng;  Sun, Ying
收藏  |  浏览/下载:52/0  |  提交时间:2022/01/10
Efficacy and safety of HLX10, a novel anti-PD-1 antibody, in patients with previously treated unresectable or metastatic microsatellite instability-high or mismatch repair-deficient solid tumors: A single-arm, multicenter, phase 2 study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Qin, Shukui;  Li, Jin;  Zhong, Haijun;  Jin, Chuan;  Chen, Lili;  Yuan, Xianglin;  Fan, Qingxia;  Chen, Kehe;  Cao, Peiguo;  Xiao, Jianjun;  Jiang, Da;  Zhang, Tao;  Zhang, Hongyu;  Wang, Xicheng;  Wang, Wei;  Wang, Qingyu
收藏  |  浏览/下载:40/0  |  提交时间:2022/01/10
Safety and efficacy of apatinib as third or later line treatment for advanced gastric cancer or gastroesophageal junction adenocarcinoma: A post-marketing phase IV study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Li, Jin;  Qin, Shukui;  Wen, Lu;  Wang, Junsheng;  Deng, Wenying;  Guo, Weijian;  Jia, Tongfu;  Jiang, Da;  Zhang, Guifang;  He, Yifu;  Zhong, Haijun;  Ba, Yi;  Lin, Xiaoyan;  Yang, Jianwei;  Zhao, Jun;  Bai, Yuxian;  Wu, Xiangyuan;  Gao, Feng;  Sun, Ying;  Hou, Zhiguo
收藏  |  浏览/下载:50/0  |  提交时间:2022/01/10